KIRKPATRICK LYNN (Chief Executive Officer) purchased 34.1% of their position (97K shares) of ENSYSCE BIOSCIENCES, INC. on the open market
Open‑market purchase worth $48.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 5/27/2022ACC: 0001493152-22-015294
DirectorOfficer· Chief Executive Officer
Since Jun 2021
+297K
Net shares
Net buyer
$48.3K
Total acquired
2
Open market trades
2B · 0S
3
Total transactions
297K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+70K
Price / share
$0.49
Trade value
$34.08K
% of position
24.6%
5/25/2022
284.85K→354.85K
Common Stock
Direct
Shares
+27K
Price / share
$0.53
Trade value
$14.22K
% of position
7.6%
5/26/2022
354.85K→381.85K
Total
Net shares
+97K
Net value
$48.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/25/2022 | P · Purchase | +70K | $0.49 | $34.08K | 24.6% | 284.85K | 354.85K |
| Common Stock Direct | 5/26/2022 | P · Purchase | +27K | $0.53 | $14.22K | 7.6% | 354.85K | 381.85K |
| Total | +97K | $48.30K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
200K shares
Shares
+200K
Strike price
1.4
Held after
2.52M
Exercisable
—
2/17/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock200K shares | 2/17/2022 | A · Award | +200K | 1.4 | — | 2.52M |